Strangvac, a vaccine against equine strangles, has been granted marketing authorisation by the European Commission
Stockholm, August 16, 2021 - Intervacc AB (“Intervacc”) announced today that the European Commission has granted a Marketing Authorisation for Strangvac within the European Union. Strangvac is a vaccine against equine strangles, a highly contagious infectious disease that affects horses globally.
“We are happy that Strangvac has received the European Commission’s approval” explained Andreas Andersson, CEO of Intervacc. “Strangvac is the first Swedish Animal Health vaccine to be approved through the centralised procedure and we feel great responsibility to spread the use the vaccine to